Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 2,310.00
+5.00 (0.22%)
At close: Apr 9, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 180 billion as of April 10, 2026. Its market cap has decreased by -45.29% in one year.
Market Cap
180.00B
Enterprise Value
263.36B
Revenue
19.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,310.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 180.00B, a decrease of -70.65%. That is a compound annual growth rate of -21.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 179.61B | -23.89% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| curacle co.,ltd. | 294.00B |
| NIBEC | 291.54B |
| Bio Solution | 270.01B |
| Genome & Company | 244.60B |
| Kangstem Biotech | 215.89B |
| ABION | 197.77B |
| Ensol Biosciences | 186.00B |
| ISU Abxis | 179.59B |